Skip to content

Booksellers & Trade Customers: Sign up for online bulk buying at trade.atlanticbooks.com for wholesale discounts

Booksellers: Create Account on our B2B Portal for wholesale discounts

Advances in Pharmaceutical Biotechnology: Volume 2: Current Developments in Biopharmaceuticals

by Vivek P. Chavda , Zhe-Sheng (Jason) Chen
Save 35% Save 35%
Current price ₹16,965.00
Original price ₹26,100.00
Original price ₹26,100.00
Original price ₹26,100.00
(-35%)
₹16,965.00
Current price ₹16,965.00

Imported Edition - Ships in 12-14 Days

Free Shipping in India on orders above Rs. 500

Request Bulk Quantity Quote
+91
Book cover type: Hardcover
  • ISBN13: 9781774919804
  • Binding: Hardcover
  • Subject: N/A
  • Publisher: Apple Academic Press
  • Publisher Imprint: Apple Academic Press
  • Publication Date:
  • Pages: 490
  • Original Price: GBP 200.0
  • Language: English
  • Edition: 1
  • Item Weight: 899 grams
  • BISAC Subject(s): Pharmaceutical

Discusses uses of novel technologies for production, formulation, and synthesis of biological substances from living organisms. Covers specialized areas in pharmaceutical technology, including biotherapeutics, principals and science of vaccinology, bioprocess and fermentation technology, therapies like gene therapy etc.

Vivek P. Chavda, MPharm, is an Assistant Professor of Pharmaceutics and Pharmaceutical Technology at the L. M. College of Pharmacy, India. Before joining academia, he served in the biologics industry for almost eight years in research and development and has two successful regulatory filings at Lupin Biotech and Dr. Reddy's Laboratory. He has published over 250 papers in national and international publications, nearly 20 book chapters, and several books, and has seven patents in progress. His research interests include development of biologics processes and formulations, medical device development, nano-diagnostics, long-acting parenteral formulations, and nano-vaccines. He is listed among the world's top 2% of scientists in 2023 and 2024 by Stanford University and Elsevier.

Zhe-Sheng (Jason) Chen, MD, PhD, a Professor at the College of Pharmacy and Health Sciences at St. John's University, New York, USA. Dr. Chen is editor-in-chief of Drug Resistance Updates, Recent Patents on Anticancer Drugs Discovery, Journal of Cancer Research Updates, and New Developments on Chemistry, as well as a guest editor for Current Pharmaceutical Biotechnology and an editorial board member and reviewer for many journals. He is also an ad hoc grants reviewer for the National Institutes of Health (USA) and NCI Special Emphasis Review Panel, OmniBus SEP-10, as well as a state grant reviewer for Louisiana and a reviewer for grants for New Zealand, Poland, China, Hungary, Netherlands, etc. The author of many papers, he was included on Stanford/Elsevier's world's top 2% scientists list in 2024. He is also a consultant to pharmaceutical, biotechnology, and health industry organizations.

Trusted for over 49 years

Family Owned Company

Secure Payment

All Major Credit Cards/Debit Cards/UPI & More Accepted

New & Authentic Products

India's Largest Distributor

Need Support?

Whatsapp Us